J&J: Q3 adjusted net profit up 18.7%
(CercleFinance.com) - Johnson & Johnson has announced Q3 2021 sales of 23.
3 billion dollars, up 10.7% y-o-y.
Sales increased in all segments; Consumer Health (+5.3%), Pharmaceuticals (+13.8%) and Medical Devices (+8%).
The company's adjusted net profit reached 6.9 billion dollars, up 18.7% y-o-y: adjusted quarterly EPS therefore reached 2.6 dollars, against 2.2 dollars in Q3 2020.
All said, J&J is raising its 2021 guidance and now anticipates FY adjusted EPS of 9.77 to 9.82 dollars (vs. 9.6 to 9.7 dollars previously).
Copyright (c) 2021 CercleFinance.com. All rights reserved.
3 billion dollars, up 10.7% y-o-y.
Sales increased in all segments; Consumer Health (+5.3%), Pharmaceuticals (+13.8%) and Medical Devices (+8%).
The company's adjusted net profit reached 6.9 billion dollars, up 18.7% y-o-y: adjusted quarterly EPS therefore reached 2.6 dollars, against 2.2 dollars in Q3 2020.
All said, J&J is raising its 2021 guidance and now anticipates FY adjusted EPS of 9.77 to 9.82 dollars (vs. 9.6 to 9.7 dollars previously).
Copyright (c) 2021 CercleFinance.com. All rights reserved.